Implantable cardioverter defibrillator: What a hospital practitioner needs to know

被引:3
|
作者
Albouaini, K. [1 ]
Mudawi, T. [1 ]
Pyatt, J. R. [1 ]
Wright, D. J. [1 ]
机构
[1] Liverpool Heart & Chest Hosp, Liverpool L14 3PE, Merseyside, England
关键词
Implantable cardioverter defibrillator; Sudden cardiac death; ICD; CARDIAC-RESYNCHRONIZATION THERAPY; NONSUSTAINED VENTRICULAR-TACHYCARDIA; NONISCHEMIC DILATED CARDIOMYOPATHY; ANTIARRHYTHMIC-DRUG THERAPY; SUDDEN-DEATH; RANDOMIZED-TRIAL; HEART-FAILURE; PREVENTION; AMIODARONE; MANAGEMENT;
D O I
10.1016/j.ejim.2009.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The implantable cardioverter defibrillator (ICD) has undergone a remarkable transformation in the last three decades, both in generator size and functionality. This, coupled with improvements in lead design, allows the simplicity of defibrillator implantation to approach that of pacemakers, with outpatient placement now feasible. Nowadays, the majority of new ICD implants are performed on primary prevention grounds with device longevity of more than 7 years. In this article, we will concisely explain the evolution of this treatment, the implantation technique, arrhythmia detection and patient follow-up. In addition, we will review the relevant clinical trials as well as prescription guidelines. (C) 2009 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:591 / 597
页数:7
相关论文
共 50 条